HLX10: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
6
Conditions studied
0
US states with sites
2
Countries
Phase breakdown
Phase 2 1
Phase 3 2
Conditions being studied
| Condition | Trials |
|---|---|
| Colorectal cancer | 2 |
| Immunotherapy | 1 |
| Metastatic Colorectal Cancer | 1 |
| Radiotherapy | 1 |
| Rectal Cancer | 1 |
| Total Neoadjuvant Therapy | 1 |
Recruiting trials involving HLX10
- A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
- A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer
Common questions
How many recruiting trials involve HLX10?
2 recruiting trials across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.